Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancer
Fu Feng(Foshan Hospital of TCM), Zhanping Xu(Foshan Hospital of TCM), Yu-Xiang Zhong(Foshan Hospital of TCM), Yuan Mai(Foshan Hospital of TCM), Wei Wei(Zhujiang Hospital), Chen Yang(Guangxi University), Huang Jian-hua(Foshan Hospital of TCM), Hua-Cai Zhu(Foshan Hospital of TCM), Pengpeng Zhao(Foshan Hospital of TCM), Fu‐Xiang Lin(Foshan Hospital of TCM)
Cited by 6
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
|European Journal of Endocrinology|2011|160